9P Circulating tumour cells (CTCs) count and PD-L1 expression in untreated extensive small cell lung cancer patients treated in the REACTION trial, a phase II study of etoposide and cis/carboplatin with or without pembrolizumab (NCT02580994)

J. Menis, P. Bironzo, G. Radj, L. Greillier,I. Monnet, L. Livi,R. Young, C. Decroisette, N. Cloarec,G. Robinet,R. Schott, R. Califano,F. De Marinis,M. Mauer, A. Pochesci, M. Silva, C. Caramella,A-M. Dingemans,C. Dive, B. Besse

Annals of Oncology(2020)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要